Nicotine addiction was on the topic list for Huberman’s latest JRE appearance, and it landed at a moment when nicotine pouches (Zyn and its competitors) have become a genuinely widespread habit among exactly the professional demographic we work with — used explicitly as a “focus tool” for deep work sessions, long drives, and high-stakes meetings. It’s worth taking that use case seriously and explaining precisely why it’s a worse trade than it feels like in the moment.
Why It Feels Like It’s Helping
Nicotine is a genuine cognitive stimulant — it increases acetylcholine and dopamine release, both of which are involved in attention and alertness. The subjective effect of a pouch during a work session is real: sharper, more alert, more “locked in.” This isn’t a placebo effect, which is exactly why the habit is so easy to justify and so hard to walk back.
What’s Actually Happening Underneath
The mechanism that produces the short-term focus boost is the same mechanism that produces dependence, and the two cannot be cleanly separated. Nicotine’s addictive potential comes from how efficiently and rapidly it triggers dopamine release in the reward pathway — one of the fastest-acting reinforcement loops of any commonly used substance. Regular use downregulates baseline dopamine receptor sensitivity over time, meaning your baseline (non-nicotine) state gradually requires more stimulation to feel normal focus and motivation. In plain terms: the tool you’re using to boost focus is quietly lowering your unassisted focus baseline the more you use it, which is precisely why the perceived need for the next pouch tends to escalate rather than stay stable.
There’s also a cardiovascular cost worth naming honestly — nicotine reliably elevates heart rate and blood pressure acutely, and habitual use is associated with adverse cardiovascular outcomes independent of the delivery method. “Smokeless” does not mean “metabolically free.”
The Trade Most Users Aren’t Actually Making Consciously
Almost nobody using pouches for focus has explicitly decided “I will trade a slowly declining baseline dopamine sensitivity and a cardiovascular cost for temporary alertness during deep work.” They’ve decided, reasonably, “this helps me focus right now,” without the second half of the trade being visible in the moment. That invisibility is exactly what makes it worth naming directly.
What We’d Actually Recommend Instead
If the goal is genuinely better focus during demanding work — not the nicotine itself — the underlying need can be met without the trade:
- Address the actual deficit — most “I need nicotine to focus” moments trace back to poor sleep the night before or a stress-dysregulated nervous system, both of which are the actual problem nicotine is temporarily masking.
- Use cold exposure or brief high-intensity movement before a demanding block — both reliably increase alertness and catecholamine release through mechanisms with no addictive liability.
- Time caffeine deliberately rather than reflexively — caffeine has its own tolerance dynamics, but a much more favorable long-term profile than nicotine for this specific use case.
- Rebuild attentional capacity directly through the progressive training approach we’ve written about separately, rather than chemically propping up a detrained system.
The Honest Bottom Line
Nicotine works for acute focus because the mechanism is real, not imagined. It’s also actively eroding the baseline capacity you’re trying to improve, in a way that’s easy to miss because the short-term effect is so reliable. If you’re using pouches as a focus tool and it’s become a daily habit rather than an occasional one, that’s worth examining honestly rather than defending as harmless because it’s not a cigarette.
Want an assessment of what’s actually driving your focus gaps, and a plan that doesn’t quietly cost you your baseline? Book a discovery call.